Zoono Secures NZ$600K UK Soft Fruits Packaging Orders
Zoono Group has secured its first major commercial orders worth NZ$600,000 from Sharpak under an exclusive UK soft fruits packaging contract, marking a key step in scaling its antimicrobial coating technology in international markets.
- First significant UK orders valued at NZ$600,000
- Second identical order scheduled for July 2026
- Minimum purchase commitments deferred by 12 months
- Recurring South African orders reach NZ$366,000
- Accelerated payment terms reflect market confidence
Sharpak Commences Commercial Orders in UK Soft Fruits Sector
Zoono Group Limited (ASX:ZNO), in partnership with OSY Group Limited, has received its first substantial commercial orders from Sharpak Aylesham Limited, the UK arm of Groupe Guillin SA, under an exclusive contract for antimicrobial-coated soft fruits packaging. The initial order, valued at approximately NZ$600,000, is to be followed by a second order of the same size in July 2026, both benefiting from accelerated payment terms that underscore the parties’ confidence in the opportunity.
Delayed Trials Push Back Purchase Commitments
The contract, inked in May 2025, grants Sharpak exclusivity across the UK soft fruits packaging market, covering rigid pots, tubs, and trays supplied to supermarket customers. An extended trial and validation phase with UK retailers concluded later than expected, delaying commercial-scale orders and prompting Zoono, OSY, and Sharpak to mutually agree on deferring the minimum annual purchase commitments by twelve months. Importantly, the total contracted volumes remain unchanged, and Sharpak’s exclusivity stands firm on original terms.
South African Orders Maintain Steady Momentum
Alongside the UK progress, Zoono confirmed that Mpact Operations (Pty) Limited in South Africa continues to place recurring orders under a November 2025 exclusive packaging agreement. With a third order valued at around NZ$122,000, total orders from Mpact now sum to approximately NZ$366,000, aligning with the anticipated commercial profile. This steady flow complements the broader international rollout of Zoono’s antimicrobial coating technology, following exclusive agreements in Australia and South Africa announced late last year.
Scaling Production and Market Adoption in Focus
From September 2026, Sharpak plans to ramp up production of coated packaging to meet growing demand from UK supermarkets, signaling an anticipated revenue growth phase for Zoono in this key market. The accelerated payment terms for the initial orders reflect a shared optimism about the commercial potential now unfolding. This development builds on recent contract wins and order inflows, including the NZ$333K increase in cash receipts from packaging partners reported in April 2026, which bolstered Zoono’s fresh food shelf-life extension business NZ$333K increase in cash receipts.
International Expansion Strategy Gains Traction
Zoono’s antimicrobial coating technology, based on its proprietary “zoono molecule,” aims to extend the shelf life and safety of fresh produce packaging sustainably. The company’s partnerships span multiple continents, with exclusive contracts in the UK, South Africa, and Australia, the latter secured through Multisteps Pty Limited in a five-year deal announced in November 2025 Exclusive five-year Australian deal. The UK orders mark a significant commercial milestone, validating the technology’s acceptance by leading supermarket chains despite earlier delays in customer adoption.
Bottom Line?
Zoono’s first major UK orders signal growing traction, but the delayed ramp-up and deferred purchase commitments suggest investors should watch closely how production scales and recurring revenues develop.
Questions in the middle?
- Will Sharpak meet the deferred minimum purchase volumes within the extended timeframe?
- How quickly can production scale to drive sustained revenue growth from September 2026?
- What impact will broader supermarket adoption have on Zoono’s international commercial rollout?
